CN113275584B - Micro-nano silver powder and preparation method and application thereof - Google Patents
Micro-nano silver powder and preparation method and application thereof Download PDFInfo
- Publication number
- CN113275584B CN113275584B CN202110549513.8A CN202110549513A CN113275584B CN 113275584 B CN113275584 B CN 113275584B CN 202110549513 A CN202110549513 A CN 202110549513A CN 113275584 B CN113275584 B CN 113275584B
- Authority
- CN
- China
- Prior art keywords
- micro
- silver powder
- nano silver
- preparation
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 82
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 150000001875 compounds Chemical class 0.000 claims abstract description 37
- 108010043958 Peptoids Proteins 0.000 claims abstract description 24
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 17
- 238000001914 filtration Methods 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- 239000000243 solution Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 19
- 239000011259 mixed solution Substances 0.000 claims description 14
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 12
- 108010016626 Dipeptides Proteins 0.000 claims description 9
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000002425 crystallisation Methods 0.000 claims description 7
- 230000008025 crystallization Effects 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- LQXLODGQLFQLAW-GDVGLLTNSA-N (2s)-2-(3-hydroxybutanoylamino)pentanedioic acid Chemical compound CC(O)CC(=O)N[C@H](C(O)=O)CCC(O)=O LQXLODGQLFQLAW-GDVGLLTNSA-N 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000010248 power generation Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 239000000645 desinfectant Substances 0.000 claims 1
- -1 beta-hydroxybutyryl-amino Chemical group 0.000 abstract description 16
- 239000002904 solvent Substances 0.000 abstract description 13
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 abstract description 12
- 239000002270 dispersing agent Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 27
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- KGJXFVOAIVSRGU-MQWKRIRWSA-N CC(O)CC(=O)N[C@@H](CCCCN)C(O)=O Chemical compound CC(O)CC(=O)N[C@@H](CCCCN)C(O)=O KGJXFVOAIVSRGU-MQWKRIRWSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000002245 particle Substances 0.000 description 9
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 3
- NMYQKDXBZKTRLS-AGROOBSYSA-N (2S)-2-[[(2S)-2-[[2-(3-hydroxybutanoylamino)acetyl]amino]propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound OC(CC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)O)C NMYQKDXBZKTRLS-AGROOBSYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- FELSNFUBVBSUPL-UZPQQBEXSA-N CC(C)C[C@@H](C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)NC(CC(C)O)=O Chemical compound CC(C)C[C@@H](C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)NC(CC(C)O)=O FELSNFUBVBSUPL-UZPQQBEXSA-N 0.000 description 3
- BQFLYHMTMWHCMF-VWMHFEHESA-N N[C@@H](CCSC)C(=O)O.OC(CC(=O)NCC(=O)O)C Chemical compound N[C@@H](CCSC)C(=O)O.OC(CC(=O)NCC(=O)O)C BQFLYHMTMWHCMF-VWMHFEHESA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 150000001370 alpha-amino acid derivatives Chemical group 0.000 description 3
- 235000008206 alpha-amino acids Nutrition 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000006068 polycondensation reaction Methods 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 3
- 229910000367 silver sulfate Inorganic materials 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001371 alpha-amino acids Chemical class 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- KPWCQEUBJAIORR-RGMNGODLSA-N ethyl (2s)-2-amino-4-methylsulfanylbutanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H](N)CCSC KPWCQEUBJAIORR-RGMNGODLSA-N 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JEDUWQDSBRHBIP-JEDNCBNOSA-N (2s)-2-amino-5-ethoxy-5-oxopentanoic acid;hydrochloride Chemical compound Cl.CCOC(=O)CC[C@H](N)C(O)=O JEDUWQDSBRHBIP-JEDNCBNOSA-N 0.000 description 1
- SYQNQPHXKWWZFS-YFKPBYRVSA-N (4s)-4-amino-5-ethoxy-5-oxopentanoic acid Chemical compound CCOC(=O)[C@@H](N)CCC(O)=O SYQNQPHXKWWZFS-YFKPBYRVSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- NOUDPBCEONUCOV-FJXQXJEOSA-N [(2s)-1-ethoxy-4-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)CC(C)C NOUDPBCEONUCOV-FJXQXJEOSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000004841 bisphenol A epoxy resin Substances 0.000 description 1
- 239000004842 bisphenol F epoxy resin Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- SGEJVUZMEHMANQ-FJXQXJEOSA-N ethyl (2s)-2,6-diaminohexanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H](N)CCCCN SGEJVUZMEHMANQ-FJXQXJEOSA-N 0.000 description 1
- PQGVTLQEKCJXKF-RGMNGODLSA-N ethyl (2s)-2-amino-3-methylbutanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)C(C)C PQGVTLQEKCJXKF-RGMNGODLSA-N 0.000 description 1
- JCXLZWMDXJFOOI-WCCKRBBISA-N ethyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@H](C)N JCXLZWMDXJFOOI-WCCKRBBISA-N 0.000 description 1
- QQGRWNMNWONMOO-LEUCUCNGSA-N ethyl (2s,3s)-2-amino-3-methylpentanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)[C@@H](C)CC QQGRWNMNWONMOO-LEUCUCNGSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- CMDGQTVYVAKDNA-UHFFFAOYSA-N propane-1,2,3-triol;hydrate Chemical compound O.OCC(O)CO CMDGQTVYVAKDNA-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- SDLBJIZEEMKQKY-UHFFFAOYSA-M silver chlorate Chemical compound [Ag+].[O-]Cl(=O)=O SDLBJIZEEMKQKY-UHFFFAOYSA-M 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01B—CABLES; CONDUCTORS; INSULATORS; SELECTION OF MATERIALS FOR THEIR CONDUCTIVE, INSULATING OR DIELECTRIC PROPERTIES
- H01B1/00—Conductors or conductive bodies characterised by the conductive materials; Selection of materials as conductors
- H01B1/20—Conductive material dispersed in non-conductive organic material
- H01B1/22—Conductive material dispersed in non-conductive organic material the conductive material comprising metals or alloys
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Manufacturing & Machinery (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
Abstract
The application provides micro-nano silver powder and a preparation method and application thereof, wherein the preparation method of the micro-nano silver powder comprises the following steps: dissolving a peptoid compound in a solvent, adding silver salt and a reducing agent, reacting, and filtering to obtain micro-nano silver powder; the peptoid compound is a beta-hydroxybutyryl-amino acid compound. According to the preparation method of the micro-nano silver powder, the peptoid compound is used as the dispersing agent, so that the preparation of the micro-nano silver powder can be realized, and the morphology, granularity and structure of the micro-nano silver powder can be adjusted by adopting the peptoid compounds with different chemical structures, so that the structure and morphology of the micro-nano silver powder can be controlled. The micro-nano silver powder prepared by the application has good dispersibility, and has specific surface area and resistivity smaller than those of commercial samples, and good performance.
Description
Technical Field
The application relates to the technical field of nano materials, in particular to micro-nano silver powder and a preparation method and application thereof.
Background
The nanometer and micrometer metal silver powder material is widely applied to the fields of electronic ceramics, solar photovoltaic power generation, sterilization, disinfection, electronic flexible printing and the like. The shape and structure of the micro-nano silver powder prepared by the current method can not be well controlled, and the structure and shape of the silver powder are directly related to the quality and performance of the prepared silver powder. Therefore, a preparation method capable of better controlling the structure and morphology of the micro-nano silver powder is needed.
Disclosure of Invention
In view of the above, the application provides micro-nano silver powder and a preparation method thereof, which aim to solve or partially solve the technical problems in the prior art.
In a first aspect, the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
dissolving a peptoid compound in a solvent, adding silver salt and a reducing agent, reacting, and filtering to obtain micro-nano silver powder;
wherein the peptoid compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula of the beta-hydroxybutyryl-amino acid is as follows:
(R) n is an alpha-amino acid substituent or is formed by polycondensation of alpha-amino acidsIs a polypeptide chain of (a).
Preferably, in the preparation method of the micro-nano silver powder, the silver salt comprises at least one of silver nitrate, silver sulfate and silver halide.
Preferably, in the preparation method of the micro-nano silver powder, the solvent comprises one of water, methanol, ethanol, ethylene glycol, glycerol and acetone.
Preferably, in the preparation method of the micro-nano silver powder, the reducing agent comprises at least one of glucose, formaldehyde, formic acid, ethylene glycol, sodium borohydride and ascorbic acid.
Preferably, in the preparation method of the micro-nano silver powder, the peptoid compound is dissolved in a solvent, then silver salt and a reducing agent are added, after the reaction, the micro-nano silver powder is obtained by filtering, wherein the reaction temperature is 80-220 ℃ and the reaction time is 180-720 min.
Preferably, in the preparation method of the micro-nano silver powder, the mass volume ratio of the peptoid compound, the silver salt, the reducing agent and the solvent is (0.5-10) g: (0.5-15) g: (0.5-18) g: (30-80 ml).
In a second aspect, the application also provides micro-nano silver powder, which is prepared by adopting the preparation method.
In a third aspect, the application also provides application of the micro-nano silver powder in preparing conductive silver paste, electronic ceramics, sterilization disinfector and solar photovoltaic power generation devices.
Compared with the prior art, the micro-nano silver powder and the preparation method and application thereof have the following beneficial effects:
(1) According to the preparation method of the micro-nano silver powder, the peptoid compound is used as the dispersing agent, so that the preparation of the micro-nano silver powder can be realized, and the morphology, granularity and structure of the micro-nano silver powder can be adjusted by adopting the peptoid compounds with different chemical structures, so that the structure and morphology of the micro-nano silver powder can be controlled.
(2) The micro-nano silver powder prepared by the method has good dispersibility, the specific surface area and the resistivity are smaller than those of commercial samples, and the micro-nano silver powder has good performance; the conductive silver paste prepared from the micro-nano silver powder has better performance than the conductive silver paste prepared from the existing silver powder.
Drawings
In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below. It is evident that the drawings in the following description are only some embodiments of the present application and that other drawings may be obtained from these drawings without inventive effort for a person of ordinary skill in the art.
FIG. 1 is a surface morphology graph of micro-nano silver powder prepared in example 1 of the present application;
FIG. 2 is a surface morphology graph of the micro-nano silver powder prepared in example 2 of the present application;
FIG. 3 is a surface morphology graph of the micro-nano silver powder prepared in example 3 of the present application;
FIG. 4 is a surface morphology graph of the micro-nano silver powder prepared in example 4 of the present application;
FIG. 5 is a surface morphology graph of the micro-nano silver powder prepared in example 5 of the present application;
FIG. 6 is a surface morphology graph of the micro-nano silver powder prepared in example 6 of the present application.
Detailed Description
The following description of the embodiments of the present application will be made in detail and with reference to the embodiments of the present application, but it should be apparent that the described embodiments are only some embodiments of the present application, and not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the present application without making any inventive effort, are intended to fall within the scope of the present application.
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
dissolving a peptoid compound in a solvent, adding silver salt and a reducing agent, reacting, and filtering to obtain micro-nano silver powder;
wherein the peptoid compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula of the beta-hydroxybutyryl-amino acid is as follows:
(R) n is an alpha-amino acid substituent or a polypeptide chain formed by polycondensation of alpha-amino acids.
It should be noted that, the peptoid compound in the embodiment of the application can be used as a dispersant to prepare micro-nano silver powder, and specifically, the peptoid compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula is as follows:the morphology, granularity and structure of the micro-nano silver powder can be adjusted by adopting different (R) n groups, so that the structure and morphology of the micro-nano silver powder can be controlled.
Specifically, in some embodiments, the α -amino acid may be alanine, arginine, aspartic acid, cysteine, glutamine, glutamic acid, histidine, isoleucine, glycine, asparagine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and the like, corresponding (R) n Is a polypeptide chain obtained by polycondensation of the above alpha-amino acids.
Specifically, in some embodiments, the β -hydroxybutyryl-amino acid compound may be specifically:
and the specific structure of the beta-hydroxybutyryl-amino acid compound and the synthesis method thereof all adopt the prior art, and the application does not improve the structure.
In some embodiments, the silver salt is a soluble or low-soluble silver salt, specifically, the silver salt includes at least one of silver nitrate, silver sulfate, and silver halide.
In some embodiments, the solvent is water or an organic alcohol or ketone having a molecular weight below 300, and the particular solvent may be one of methanol, ethanol, ethylene glycol, glycerol, and acetone.
In some embodiments, the reducing agent includes at least one of glucose, formaldehyde, formic acid, ethylene glycol, sodium borohydride, and ascorbic acid.
In some embodiments, the peptoid compound is dissolved in a solvent, then silver salt and a reducing agent are added, and after the reaction, the micro-nano silver powder is obtained by filtration, wherein the reaction temperature is 80-220 ℃ and the reaction time is 180-720 min.
In some embodiments, the peptoid compound is dissolved in a solvent, then silver salt and a reducing agent are added, after the reaction, the mixture is filtered, and then the filtered material is washed by ethanol and deionized water to remove organic matters and impurity salts on the surface of the filtered material, thus obtaining the micro-nano silver powder
In some embodiments, the mass to volume ratio of peptoid compound, silver salt, reducing agent, and solvent is (0.5-10) g: (0.5-15) g: (0.5-18) g: (30-80 ml).
Based on the same inventive concept, the application also provides micro-nano silver powder, which is prepared by adopting the preparation method.
Based on the same inventive concept, the application also provides application of the prepared micro-nano silver powder in preparing conductive silver paste, electronic ceramics, sterilization disinfector and solar photovoltaic power generation device.
The method for preparing the micro-nano silver powder of the present application is further described in the following specific examples.
Example 1
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 1.8g of silver nitrate and 1.6g of peptoid compound into 60mL of ethanol, adding 2g of reducing agent ascorbic acid, stirring for 30min, and uniformly mixing the solutions to obtain a mixed solution; and (3) placing the prepared mixed solution into a crystallization kettle, heating to 120 ℃, keeping the temperature for 720 minutes, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder.
Wherein, the peptide-like compound is beta-hydroxybutyryl-lysine pseudo dipeptide, and the structural formula is:
specifically, the preparation method of the beta-hydroxybutyryl-lysine pseudo dipeptide comprises the following steps:
s1, adding 0.01mol of tert-butyl dimethyl silyl ether beta-hydroxybutyric acid, 0.01mol of lysine ethyl ester hydrochloride and 0.001mol of 4-dimethylaminopyridine into 50ml of dichloromethane, stirring, then adding 0.024mol of triethylamine, and stirring and reacting for 20min to obtain a reaction solution;
s2, dissolving 0.015mol of N, N' -dicyclohexylcarbodiimide in 20mL of dichloromethane, then dripping the reaction solution, stirring for 3 hours at room temperature after dripping, carrying out suction filtration, respectively washing the filtrate twice with 50mL of water and 20mL of 0.1M dilute hydrochloric acid twice, washing once with 20mL of saturated sodium bicarbonate water solution and 20mL of saturated sodium chloride water solution, drying a dichloromethane phase, and concentrating;
s3, dissolving the condensed concentrated solution with 50mL of tetrahydrofuran, adding 1 equivalent of tetrabutylammonium fluoride, stirring at room temperature for 1h, then adding water for quenching reaction, evaporating tetrahydrofuran under reduced pressure, extracting water phases with 30mL of dichloromethane for 3 times, merging organic phases, washing once with 30mL of saturated sodium chloride, concentrating, adding 1 equivalent of 1M aqueous sodium hydroxide solution into the concentrated solution, keeping the pH value at 7-8, stirring for 1h, washing the reaction solution with 20mL of dichloromethane for three times, concentrating the water phases, recrystallizing with ethanol/acetone to obtain 1.5g of white solid, namely beta-hydroxybutyryl-lysine pseudo dipeptide sodium salt, wherein the yield is 62.5%, adding an equivalent of hydrogen chloride ethanol solution into the beta-hydroxybutyryl-lysine pseudo dipeptide sodium salt, filtering, concentrating, and obtaining the beta-hydroxybutyryl-lysine pseudo dipeptide as white solid. The nuclear magnetic data of the beta-hydroxybutyryl-lysine pseudo dipeptide are: 1HNMR (400 MHz, D) 2 O)δ4.02(m,1H),3.62(m,1H),3.02(m,2H),2.27(m,2H),1.61(m,2H),1.30(m,2H),1.25(m,2H),1.13(m,3H)。
Example 2
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 2.4g of silver nitrate and 2.8g of peptoid compound into 60mL of ethanol water solution, adding 2.8g of reducing agent glucose, and stirring for 50min to uniformly mix the solutions to obtain a mixed solution; and (3) placing the prepared mixed solution into a crystallization kettle, heating to 160 ℃, keeping the temperature for 480 minutes, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of ethanol to water in the ethanol water solution is 1:1.
Wherein, the peptide-like compound is beta-hydroxybutyryl-glutamic acid pseudo dipeptide, and the structural formula is:
specifically, the preparation method of the beta-hydroxybutyryl-glutamic acid pseudo-dipeptide can be referred to as the preparation method of the beta-hydroxybutyryl-lysine pseudo-dipeptide in example 1, and specifically, the beta-hydroxybutyryl-glutamic acid pseudo-dipeptide is prepared from tert-butyldimethylsilyl ether beta-hydroxybutyrate and ethyl glutamate hydrochloride. The prepared beta-hydroxybutyryl-glutamic acid pseudo dipeptide nuclear magnetic hydrogen spectrum data are as follows: 1 H NMR(400MHz,D 2 O)δ4.23(m,1H),4.15(m,1H),2.49(m,2H),2.25(m,2H),2.09(m,1H),1.92(m,1H),1.26(d,3H)。
example 3
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 0.6g of silver sulfate and 1.8g of peptoid compound into 60mL of acetone aqueous solution, adding 1.2g of reducing agent ascorbic acid, stirring for 100min, and uniformly mixing the solutions to obtain a mixed solution; and (3) placing the prepared mixed solution into a crystallization kettle, heating to 200 ℃, keeping the temperature for 600 minutes at constant temperature, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of acetone to water in the acetone aqueous solution is 1:1.
Wherein, the peptide-like compound is beta-hydroxybutyryl-glycine-methionine pseudo tripeptide, and the structural formula is as follows:specifically, the preparation method of the beta-hydroxybutyryl-glycine-methionine pseudo-tripeptide can be referred to as the preparation method of the beta-hydroxybutyryl-lysine pseudo-dipeptide in example 1, and specifically, the beta-hydroxybutyryl-tert-butyldimethylsilyl ether beta-hydroxybutyrate, glycine ethyl ester hydrochloride and methionine ethyl ester hydrochloride are prepared. The prepared beta-hydroxybutyryl-glycine-methionine pseudo tripeptide nuclear magnetic hydrogen spectrum data are as follows: 1 H NMR(400MHz,D 2 O)δ4.21(m,1H),4.07(m,1H),3.84(m,2H),2.35(m,4H),2.00(m,1H),1.98(s,3H),1.80(m,1H),1.13(d,3H)。
example 4
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 0.6g of silver chlorate and 1.8g of peptoid compound into 60mL of acetone aqueous solution, adding 2.0g of reducing agent formaldehyde solution, stirring for 100min, and uniformly mixing the solutions to obtain mixed solution; and (3) placing the prepared mixed solution into a crystallization kettle, heating to 180 ℃, keeping the temperature for 600 minutes at constant temperature, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of acetone to water in the acetone aqueous solution is 1:1.
Wherein the peptide-like compound is beta-hydroxybutyryl-glycine-isoleucine pseudo tripeptide, and the structural formula is as follows:
specifically, the preparation method of the beta-hydroxybutyryl-glycine-isoleucine pseudo-tripeptide can be referred to as the preparation method of the beta-hydroxybutyryl-lysine pseudo-dipeptide in example 1, and specifically, the beta-hydroxybutyryl-tert-butyldimethylsilyl ether beta-hydroxybutyrate, glycine ethyl ester hydrochloride and isoleucine ethyl ester hydrochloride are prepared. The prepared beta-hydroxybutyryl-glycine-isoleucine pseudo-tripeptide nuclear magnetic hydrogen spectrum data are as follows: 1 H NMR(400MHz,D 2 O)δ4.21(m,1H),4.07(m,1H),3.84(m,2H),2.35(m,4H),2.00(m,1H),1.98(s,3H),1.80(m,1H),1.13(d,3H)。
example 5
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 2.6g of silver nitrate and 1.8g of peptoid compound into 60mL of glycerol water solution, adding 2.0g of reducing agent sodium borohydride, stirring for 100min, and uniformly mixing the solutions to obtain a mixed solution; and (3) placing the prepared mixed solution into a crystallization kettle, heating to 160 ℃, keeping the temperature for 480 minutes, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of glycerol to water in the glycerol aqueous solution is 1:1.
Wherein the peptide-like compound is beta-hydroxybutyryl-glycyl-alanyl-methionine pseudo-tetrapeptide, and the structural formula is as follows:
specifically, the method for preparing the pseudo-tetrapeptide of beta-hydroxybutyryl-glycyl-alanyl-methionine can be referred to as the method for preparing the pseudo-dipeptide of beta-hydroxybutyryl-lysine in example 1, specifically, the method comprises the steps of preparing tert-butyl dimethyl silyl ether beta-hydroxybutyric acid, glycine ethyl ester hydrochloride, alanine ethyl ester hydrochloride and methionine ethyl ester hydrochloride. The prepared beta-hydroxybutyryl-glycyl-alanyl-methionine pseudo-tetrapeptide nuclear magnetic hydrogen spectrum data are as follows: 1 H NMR(400MHz,D 2 O)δ4.31(m,1H),4.22(m,1H),4.12(m,1H),3.84(m,2H),2.57(m,2H),2.37(m,2H),2.05(s,3H),1.95(m,2H),1.32(d,3H)。
example 6
The embodiment of the application provides a preparation method of micro-nano silver powder, which comprises the following steps:
adding 1.6g of silver nitrate and 0.8g of peptoid compound into 60mL of glycol water solution, adding 2.4g of reducing agent formic acid, stirring for 100min, and uniformly mixing the solutions to obtain a mixed solution; and (3) placing the prepared mixed solution into a crystallization kettle, heating to 150 ℃, keeping the temperature for 660 minutes, filtering, and cleaning with ethanol and deionized water to obtain the micro-nano silver powder, wherein the volume ratio of the glycol to the water in the glycol aqueous solution is 1:1.
Wherein the peptide-like compound is beta-hydroxybutyryl-leucyl-valyl-glutamic acid pseudo-tetrapeptide, and the structural formula is as follows:
specifically, the preparation method of the beta-hydroxybutyryl-leucyl-valyl-glutamic acid pseudotetrapeptide can be referred to as the preparation method of the beta-hydroxybutyryl-lysine pseudodipeptide in example 1, and specifically, the beta-hydroxybutyryl-tert-butyldimethylsilyl ether beta-hydroxybutyrate, leucine ethyl ester hydrochloride, valine ethyl ester hydrochloride and glutamic acid ethyl ester hydrochloride are prepared. The prepared beta-hydroxybutyryl-leucyl-valyl-glutamic acid pseudo-tetrapeptide nuclear magnetic hydrogen spectrum data are as follows: 1 H NMR(400MHz,D 2 O)δ4.25(m,2H),4.06(m,1H),3.94(m,1H),2.51(m,2H),2.35(m,2H),2.11(m,2H),1.98(m,1H),1.52(m,3H),1.11(d,3H),0.76(m,12H)。
the results of testing the surface morphology of the micro-nano silver powder prepared in the above examples 1 to 6 are shown in fig. 1 to 6, respectively.
From fig. 1 to 6, it can be seen that the micro-nano silver powder prepared in different embodiments has uniform distribution and good dispersibility, and the micro-nano silver powder prepared in different embodiments has different particle sizes and surface morphologies. Specifically, as can be seen from fig. 1, the micro-nano silver powder prepared in example 1 is granular, and the average particle size is between 58 and 100 nm. As can be seen from FIG. 2, the micro-nano silver powder prepared in example 2 is in the shape of a sheet, and the average particle size is between 2 and 5 μm. As can be seen from FIG. 3, the micro-nano silver powder prepared in example 3 is in the shape of a sheet, and the average particle size is between 2 and 20 μm. As can be seen from FIG. 4, the micro-nano silver powder prepared in example 3 is in the form of particles with an average particle size of 0.3-0.7 μm. As can be seen from FIG. 5, the micro-nano silver powder prepared in example 5 is in the form of particles with an average particle size of 0.3-0.5 μm. As can be seen from FIG. 6, the micro-nano silver powder prepared in example 6 is granular, and the average particle size is between 90 and 220 nm.
The specific surface areas and the specific resistivities of the micro-nano silver powder and the commercially available micro-nano silver powder prepared in examples 1 to 6 were measured, and the results are shown in table 1 below. Wherein, the specific surface area adopts BET specific surface area test method, and the resistivity test method is: an ST 2742B-type automatic powder resistivity tester manufactured by Suzhou lattice electronics Inc. is adopted, and the listed data are resistivity data of the sample to be tested under 28-30 MPa.
TABLE 1 specific surface area and resistivity data for different samples
As can be seen from the above Table 1, the specific surface area of the micro-nano silver powder prepared by the method is smaller than that of the commercial sample with the same shape, and the resistivity is obviously smaller than that of the commercial sample with the same shape.
The micro-nano silver powder prepared in the embodiment 2 and a commercial sample with the same shape as the embodiment 2 are further used for preparing the photovoltaic heterojunction conductive silver paste. The specific preparation method comprises the following steps: and (3) uniformly mixing the organic systems, adding the micro-nano silver powder or the commercial sample prepared in the embodiment 2, uniformly mixing by a planetary gravity mixer, and finally mixing by a three-roller machine to obtain the photovoltaic heterojunction conductive silver paste. Wherein the organic system comprises: the adhesive comprises an adhesive phase, a solvent and an auxiliary agent, wherein the adhesive phase comprises a mixture of bisphenol A epoxy resin and bisphenol F epoxy resin, the solvent is a DBE dibasic acid ester mixture, and the auxiliary agent comprises a mixture of a defoaming agent, a thixotropic agent, a lubricant and a curing agent.
The viscosity of the prepared conductive silver paste is tested to be 28-30 ten thousand cps by using a Bohler flywheel viscometer.
The heterojunction battery cells of 156 x 156 were selected, and the battery cells were prepared by using the micro-nano silver powder in example 2 and the conductive silver paste prepared by the method with the commercial sample of example 2 through procedures of screen printing, curing, light injection and the like, and the open circuit voltage Uoc, the short circuit current Isc, the filling factor FF, the conversion efficiency Eta and the resistance Rser were tested, and the results are shown in the following table 2.
TABLE 2 Performance of the battery plates prepared from different conductive silver pastes
Battery piece | Uoc(V) | Isc(A) | FF(%) | Eta(%) | Rser(Ohm) |
Battery piece 1 | 0.7494 | 9.3435 | 84.02 | 24.023 | 0.0025 |
Battery piece 2 | 0.7494 | 9.3459 | 83.24 | 23.676 | 0.0033 |
In table 2, the battery piece 1 is a battery piece prepared by using the low-temperature conductive silver paste prepared by using the micro-nano silver powder in the above example 2, and the battery piece 1 is a battery piece prepared by using the low-temperature conductive silver paste prepared by using the commercial sample with the same morphology as the example 2. From table 2, it can be seen that the battery piece 1 has better performance, and thus, the performance of the conductive silver paste prepared from the micro-nano silver powder prepared by the method is better than that of the conductive silver paste prepared from silver powder on the market in China.
The foregoing description of the preferred embodiments of the application is not intended to be limiting, but rather is intended to cover all modifications, equivalents, alternatives, and improvements that fall within the spirit and scope of the application.
Claims (3)
1. The preparation method of the micro-nano silver powder is characterized by comprising the following steps of:
adding 2.4g of silver nitrate and 2.8g of peptoid compound into 60mL of ethanol water solution, adding 2.8g of reducing agent glucose, and stirring for 50min to uniformly mix the solutions to obtain a mixed solution; placing the prepared mixed solution into a crystallization kettle, heating to 160 ℃, keeping the temperature for 480 minutes, filtering, and cleaning with ethanol and deionized water to obtain micro-nano silver powder, wherein the volume ratio of ethanol to water in an ethanol water solution is 1:1;
wherein, the peptide-like compound is beta-hydroxybutyryl-glutamic acid pseudo dipeptide, and the structural formula is:
2. the micro-nano silver powder is characterized by being prepared by the preparation method according to claim 1.
3. The application of the micro-nano silver powder in preparing conductive silver paste, electronic ceramics, sterilization disinfectants and solar photovoltaic power generation devices according to claim 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110549513.8A CN113275584B (en) | 2021-05-20 | 2021-05-20 | Micro-nano silver powder and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110549513.8A CN113275584B (en) | 2021-05-20 | 2021-05-20 | Micro-nano silver powder and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113275584A CN113275584A (en) | 2021-08-20 |
CN113275584B true CN113275584B (en) | 2023-11-14 |
Family
ID=77280222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110549513.8A Active CN113275584B (en) | 2021-05-20 | 2021-05-20 | Micro-nano silver powder and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113275584B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115780821B (en) * | 2022-11-28 | 2024-06-11 | 苏州银瑞光电材料科技有限公司 | Preparation method of high tap density flake silver powder |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586774A (en) * | 2004-07-06 | 2005-03-02 | 中国乐凯胶片集团公司 | Process for preparing nano silver colloidal water solution |
KR20090073929A (en) * | 2007-12-31 | 2009-07-03 | 주식회사 휘닉스피디이 | Method of manufacturing silver powder |
JP2009221598A (en) * | 2008-01-17 | 2009-10-01 | Mitsubishi Materials Corp | Method for synthesizing metal nanoparticle |
CN102120265A (en) * | 2010-01-07 | 2011-07-13 | 中国科学院化学研究所 | Preparation method of colloid of mono-dispersed silver nano particles and nano silver powder and conductive ink thereof |
CN103302305A (en) * | 2013-06-09 | 2013-09-18 | 佛山市天宝利太阳能科技有限公司 | Method for preparing silver nanowires by using biomolecular amino acid as reducing agent |
KR101484743B1 (en) * | 2013-08-13 | 2015-01-26 | 고려대학교 산학협력단 | Preparation method of metal nanostructures based on biomolecules |
CN108017555A (en) * | 2017-11-28 | 2018-05-11 | 郑州海斯威生物技术有限公司 | A kind of beta-hydroxy butyryl-amino-acid compound and preparation method and application |
CN108015299A (en) * | 2017-11-06 | 2018-05-11 | 珠海纳金科技有限公司 | Nano-Ag particles and preparation method thereof |
WO2019088509A1 (en) * | 2017-10-31 | 2019-05-09 | 엘에스니꼬동제련 주식회사 | Surface-treated silver powder and preparation method therefor |
CN110303168A (en) * | 2019-08-06 | 2019-10-08 | 郴州市金贵银业股份有限公司 | A kind of preparation method of nano-silver powder |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8461300B2 (en) * | 2010-03-22 | 2013-06-11 | Sandia Corporation | Materials and methods for stabilizing nanoparticles in salt solutions |
CN105834449B (en) * | 2016-05-04 | 2017-09-22 | 苏州思美特表面材料科技有限公司 | It is a kind of that the preparation method for producing silver powder is induced by the use of micro-nano bubble as crystal seed |
-
2021
- 2021-05-20 CN CN202110549513.8A patent/CN113275584B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586774A (en) * | 2004-07-06 | 2005-03-02 | 中国乐凯胶片集团公司 | Process for preparing nano silver colloidal water solution |
KR20090073929A (en) * | 2007-12-31 | 2009-07-03 | 주식회사 휘닉스피디이 | Method of manufacturing silver powder |
JP2009221598A (en) * | 2008-01-17 | 2009-10-01 | Mitsubishi Materials Corp | Method for synthesizing metal nanoparticle |
CN102120265A (en) * | 2010-01-07 | 2011-07-13 | 中国科学院化学研究所 | Preparation method of colloid of mono-dispersed silver nano particles and nano silver powder and conductive ink thereof |
CN103302305A (en) * | 2013-06-09 | 2013-09-18 | 佛山市天宝利太阳能科技有限公司 | Method for preparing silver nanowires by using biomolecular amino acid as reducing agent |
KR101484743B1 (en) * | 2013-08-13 | 2015-01-26 | 고려대학교 산학협력단 | Preparation method of metal nanostructures based on biomolecules |
WO2019088509A1 (en) * | 2017-10-31 | 2019-05-09 | 엘에스니꼬동제련 주식회사 | Surface-treated silver powder and preparation method therefor |
CN108015299A (en) * | 2017-11-06 | 2018-05-11 | 珠海纳金科技有限公司 | Nano-Ag particles and preparation method thereof |
CN108017555A (en) * | 2017-11-28 | 2018-05-11 | 郑州海斯威生物技术有限公司 | A kind of beta-hydroxy butyryl-amino-acid compound and preparation method and application |
CN110303168A (en) * | 2019-08-06 | 2019-10-08 | 郴州市金贵银业股份有限公司 | A kind of preparation method of nano-silver powder |
Non-Patent Citations (6)
Title |
---|
Hagar Tigger-Zaborov等.Aggregation of Ag(0) nanoparticles to unexpected stable chain-like assemblies mediated by 2,20 -bipyridine decorated peptoids.Journal of Colloid and Interface Science.2019,第533卷598-603. * |
余家会等.纳米生物医药.华东理工大学出版社,2011,第15页. * |
化学还原法制备不同形貌的纳米银粉;田晓霞;张武森;赵云飞;司丹丹;胡军洲;;信息记录材料(04);第21-24页 * |
姜姗姗等.现代纳米材料及其技术应用研究.中国原子能出版社,2019,第106-110页. * |
肽基纳米材料及其应用;黄仁亮;齐崴;姜楠;苏荣欣;何志敏;;化学进展(12);第2328-2337页 * |
金征宇.基因与纳米探针:医学分子成像理论与实践.天津科学技术出版社,2017,第625-626页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113275584A (en) | 2021-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113275584B (en) | Micro-nano silver powder and preparation method and application thereof | |
CN102407341B (en) | surface modified particle diameter mixed silver powder and preparation method thereof | |
CN108866561A (en) | A kind of preparation method and applications of electro-catalysis carbon dioxide reduction electrode | |
CN109065217A (en) | HJT solar low-temperature conductive silver paste and the preparation method and application thereof | |
JP2011505430A (en) | Conductive nanoparticle inks and pastes and application methods using them | |
CN113351227A (en) | Ultra-thin Ti3C2nanosheet/ZnIn2S4Preparation method of flower ball composite photocatalyst | |
CN111269432B (en) | Two-dimensional covalent organic framework material and preparation and application thereof | |
CN108565041A (en) | A kind of high conductance proper alignment type low temperature silver paste and preparation method thereof | |
CN111905827B (en) | Preparation method of nickel-based heterogeneous composite material and application of nickel-based heterogeneous composite material in catalyzing methanol oxidation | |
Zhu et al. | Elimination of defect and strain by functionalized CQDs dual-engineering for all-inorganic HTMs-free perovskite solar cells with an ultrahigh voltage of 1.651 V | |
CN110170647A (en) | A kind of preparation method of photovoltaic cell positive silver paste super fine silver powder | |
CN112903761B (en) | Molybdenum disulfide-reduced graphene oxide-cuprous oxide ternary composite material and preparation method and application thereof | |
CN104668572A (en) | Silver powder and silver paste for back electrode of solar cell and solar cell | |
TW201307208A (en) | Micro-scaled flake silver particles and method for producing the same | |
CN111822055A (en) | Preparation method and application of BiOBr/COF composite photocatalyst | |
CN114944326B (en) | Boron slurry for HBC battery and preparation method thereof | |
CN112675836B (en) | Platinum nanoparticle/carbon nitride/bismuth oxybromide composite material, sensitized photoelectrochemical sensor and preparation method and application thereof | |
CN107413367B (en) | High-dispersion cobalt ferrite nanoparticle loaded oxa-carbon nitride and preparation method thereof | |
CN113480741B (en) | Chelating Cu 2+ Preparation method of metal organic framework material and application of metal organic framework material in chitosan composite anion membrane | |
CN106064828A (en) | Solid phase method prepares the method for Zinc oxide powder | |
CN117711665A (en) | Graphene coated silver powder, heterojunction low-temperature silver paste and preparation method thereof | |
JP2010077520A (en) | Method for producing fine copper particle, and fine copper particle | |
CN111270089A (en) | Mesoporous antimony material and preparation method thereof | |
CN114192769B (en) | Silver powder with flower-like structure and preparation method thereof | |
CN113201141B (en) | Preparation method of nickel isomorphic MOFs and application of nickel isomorphic MOFs in electrocatalysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240105 Address after: No. 3 North Xinzhuang Village Street, Wulongkou Town, Jiyuan City, Henan Province, 459000 Patentee after: Jiyuan Xinghan New Materials Technology Co.,Ltd. Address before: 215200 east side of Chang'an Road, Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province Patentee before: Suzhou Xinghan New Material Technology Co.,Ltd. |